Summary of Purpose
The study is to attain early recognition of the unstable plaques which have an imminent embolic risk in patients with intracranial atherosclerotic disease (IAD).Read More →
The following dates are available for this trial. Trial information last updated on 20 September 2017.
|1 Feb 2010||20 Sep 2017||20 Dec 2020||31 Dec 2020||1 Sep 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Thomas Wai Hong LEUNG, FRCP